ChemComm
COMMUNICATION
Ch
D
e
O
m
I: 1
i
0
ca.1
l
0
C
39
o
/
m
C4
m
CC
u
0
n
8
i
4
c
1
a
4
t
D
ion
TPy
Do
there was very low absorbance of
Ala . Therefore, these Electronic Supplementary Information
(
ESI
)
available: [Synthesis,
4
d
1
two triazolyl amino acids should form a FRET pair in our characterisation data, spectroscopic data, macromodel study and H and
1
3
designed pentapeptide
5
Do
where the conceptual donor amino acid
Ala acted as FRET donor and acceptor,
C NMR spectra]. See DOI: 10.1039/b000000x/
TPhen
Do
TPy
Ala and
1
2
3
(a) D. S. Kemp, Trends Biotechnol., 1990, 8, 249. (b) R.
Hirschmann, Angew. Chem. Int. Ed. Engl., 1991, 30, 1278. (c) J.
P. Schneider and J. W. Kelly, Chem. Rev., 1995, 95, 2169. (d) L.
R. Whitby and D. L. Boger, Acc. Chem. Res., 2012, 45, 1698.
(a) L. M. Johnson and S. H. Gellman, Methods Enzymol., 2013,
523, 407. (b) J. S. Nowick, Acc. Chem. Res., 2008, 11, 1319. (c)
W. A. Loughlin, J. D. A. Tyndall, M. P. Glenn, T. A. Hill and D.
P. Fairlie, Chem. Rev., 2010, 110, PR32ꢀPR69.
respectively. With this observation we turned our attention to
1
3
study the FRET process in detail. Thus, when excited at
TPhen
Do
absorption maximum of the donor,
Ala
(λex = 300 nm), it
was observed that the fluorescence intensity of the acceptor,
TPy
Do
Ala , increased from that of the free acceptor emission by
almost fourꢀfive times in presence of donor in peptide . On the
5
TPhen
Do
other hand, the fluorescence intensity of the donor,
in peptide decreased almost three times of that of the free
donor fluorescence in presence of acceptor,
ratiomatric change in fluorescence intensity of donor/acceptor
Ala ,
(a) C. M. Wilmot and J. M. Thornton, J. Mol. Biol., 1988, 203,
5
2
3
21. (b) R. A. Wiley and D. H. Rich, Med. Res. Rev., 1993, 13,
27. (c) Y. L. Angell and K. Burgess, Chem. Soc. Rev., 2007, 36,
TPy
Do
Ala . This
1674. (d) R. F. Hirschmann, K. C. Nicolaou, A. R. Angeles, J. S.
Chen and A. B. Smith, Acc. Chem. Res., 2009, 42, 1511. (e) A.
Basak, S. S. Bag and A. Basak, Bioorg. Med. Chem.,
TPhen
Do
revealed the visual evidence of FRET process from
to
Ala
TPy
Do
13c
Ala in peptide 5 (Fig. 5A). The calculated Förster
2
005, 13, 4096. (f) S. Hanessian, X. Luo and R. Schaum,
radius (R ), the efficiency of energy transfer (E) and the donorꢀ
0
Tetrahedron Lett., 1999, 40, 4925. (g) K.Y. Tsang, H. Diaz, N.
Graciani and J. W. Kelly, J. Am. Chem. Soc., 1994, 116, 3988. (h)
A. A. Fuller, D. Du, F. Liu, J. E. Davoren, G. Kroon, E. T.
Powers, P. Wipf, M. Gruebele and J. W. Kelly, Proc. Natl. Acad.
Sci., 2009, 106, 11067. (i) R. R. Gardner, G. B. Liang and S. H.
Gellman, J. Am. Chem. Soc., 1999, 121, 1806. (j) Gruner, S. A.
W.; Locardi, E.; Lohof, E.; Kessler, H. Chem. Rev. 2002, 102,
491. (k) J. Xie, N. Bogliotti, Chem. Rev., 2014, 114, 7678.
acceptor distance (r) were found to be 31 Å, 85% and 28 Å,
respectively. The occurrence of FRET process was also evident
from a time resolved fluorescence study wherein we observed a
TPhen
Do
decrease in donor life time (
Ala ; λex = 293 nm, λem = 370
nm) from 13.7 ns to 2.0 ns. More interestingly, the lifetime of
TPy
Do
acceptor ( Ala ; λex = 293 nm, λem = 400 nm) in presence of
donor was found to increase from 18.2 ns (in absence of donor)
to 19.0 ns (in presence of donor) evidencing the FRET process
4
(a) S. S. Bag, S. Talukdar and S. K. Das, Curr. Protocols Nucleic
Acids Chem., 2014, 58:1.32.1ꢀ1.32.27. (b) S. S. Bag, S. Talukdar,
R. Kundu, I. Saito and S. Jana, Chem. Commun., 2014, 50, 829.
1
3d
(
Fig. 5B, and ESI†, Section 13).
(c) S. S. Bag, S. Jana, A. Yashmeen, K. Senthilkumar and R. Bag,
Chem. Commun., 2014, 50, 433.
V. V. Rostovtsev, L. G. Green, V. V. Fokin and Sharpless, K. B.
Angew. Chem., Int. Ed., 2002, 41, 2596.
(a) A. Tam, U. Arnold, M. B. Soellner, R. T. Raines, J. Am.
Chem. Soc., 2007, 129, 12670. (b) A. Dirksen and P. E. Dawson,
Curr. Opin. Chem. Biol., 2008, 12, 760. (c) Y. L. Angell and K.
Burgess, Chem. Soc. Rev., 2007, 36, 1674.
Conclusions
In conclusion, the easily accessible aliphatic and aromatic
triazolo amino acids and , respectively, were introduced for
the first time, as βꢀturnꢀmimetic constrained molecular
scaffolds. The structural and conformational analysis of Leuꢀ
5
6
1
2
7
8
J. V. Aldrich, In Burger’s Medicinal Chemistry and Drug
Discovery, Vol. 3; M. E. Wolff, Ed.; John Wiley & Sons: New
York, 1996, 321ꢀ441 and references therein.
(a) R. W. Woody, In Circular Dichroism. Principles and
Applications; K. Nakanishi, N. Berova and R. W. Woody, Eds.,
1994, 473–496, VCH, New York. (b) Y. H. Chen and J. T. Yang,
Biochem. Biophys. Res. Commun., 1971, 44, 1285. (c) M. J.
Krysmann, V. Castelletto, A. Kelarakis, I. W. Hamley, R. A. Hule
and D. J. Pochan, Biochemistry, 2008, 47, 4597.
(a) K. Oh and Z. Guan, Chem. Commun., 2006, 3069. (b) A.
FeherꢀVoelger, J. BorgesꢀGonzlez, R. Carrillo, E. Q. Morales, J.
GonzlezꢀPlatas and T. Martn, Chem. Eur. J., 2014, 20, 1.
H. Kessler, Angew. Chem., Int. Ed. Engl., 1982, 21, 512.
(a) MacroModel, Version 9.9 Schrodinger, LLC, New York, NY,
enkephalin analogue peptide
3 and fluorescent peptide 5 by
various spectroscopic techniques and MD simulation studies
established wellꢀdefined type II βꢀturn structure induced by the
novel βꢀturnꢀmimetic constrained molecular scaffold, the
triazolo amino acid
process in peptide
1
5
. Moreover, we established the FRET
containing a new class of fluorescent
unnatural triazolyl amino acids at the two termini. Under study
are the explorations of turn mimetic and other analogues in
details and the sequence specific DNA binding event of tetraꢀ
amides of these molecular scaffolds which might lead to the
generation of a new family of distamycin analogues.
2
9
1
1
0
1
2
1
012. (b) I. W. Kolossvry and C. Guida, J. Am. Chem. Soc.,1996,
18, 5011.
This work was funded to S. S. Bag by the CSIR [01(2330)/09/EMRꢀII],
Govt. of India. SJ and AY are thankful to CSIR for their fellowships. We
are thankful to Professor S. Ghosh and Mr. Mohitosh Dey, Department of
Biotechnology, for using the CD spectropolarimeter facility.
1
2
T. Yamazaki, D. F. Mierke, O. E. SaidꢀNejad, E. R. Felder and M.
Goodman, Int. J. Pept. Protein Res., 1992, 39, 161.
13 (a) T. Förster, Discuss. Faraday Soc., 1959, 7. (b) J. M. G.
Rogers, L. G. Lippert and F. Gai, Anal. Biochem., 2010, 399,
1
82. (c) R. J. Nedumparaa, P. J. Manua, C.P.G. Vallabhanb,
V.P.N. Nampooria, P. Radhakrishnana, Opt. Laser Tech., 2008,
0, 953. (d) C. Banerjee, N. Kundu, S. Ghosh, S. Mandal, J.
Notes and references
Bioorganic Chemistry Laboratory, Department of Chemistry, Indian
Institute of Technology Guwahati, North Guwhatiꢀ781039, Assam, India.
4
Fax:
+91ꢀ361ꢀ258ꢀ2349;
Tel:
+91ꢀ361ꢀ258ꢀ2324.Eꢀmail:
Kuchlyan and N. Sarkar, J. Phys. Chem., B 2013,117, 9508.
4
| Chem. Commun., 2014, 00, 1-4
This journal is © The Royal Society of Chemistry 2014